Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
12.80
-0.01 (-0.08%)
At close: Jun 18, 2025, 4:00 PM
13.37
+0.57 (4.45%)
Pre-market: Jun 20, 2025, 5:22 AM EDT
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $332.99 million as of June 20, 2025. Its market cap has decreased by -4.25% in one year.
Market Cap
332.99M
Enterprise Value
352.90M
1-Year Change
-4.25%
Ranking
Category
Stock Price
$12.80
Market Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $332.99M, a decrease of -3.77%. That is a compound annual growth rate of -0.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 332.99M | 315.72% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 704.75B |
| Johnson & Johnson | 362.67B |
| Novo Nordisk | 331.06B |
| AbbVie | 327.65B |
| UnitedHealth Group | 278.67B |
| Abbott Laboratories | 230.37B |
| Novartis AG | 227.75B |
| AstraZeneca | 220.36B |